Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. ADMA Biologics Inc.’s current trading price is -8.37% away from its 52-week high, while its distance from the 52-week low is 114.13%. The stock’s price range over this period has fluctuated between $1.84 and $4.30. The company, operating within the financial sector, had a trading volume of approximately 2.06 million for the day, which was noticeably lower than the average daily share volume of 2.43 million over the last 3 months.
At present, ADMA Biologics Inc. (ADMA) has a stock price of $3.94. In the previous session, the stock saw a rise, peaking at $4.01 after an opening price of $4.00. The day’s lowest price was $3.84, and it closed at $4.03.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
ADMA Biologics Inc.’s market performance has been stable in recent times. The company’s stock hit a 1-year high of $4.30 on 05/15/23 and a low of $1.84 for the same time frame on 05/26/22.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
ADMA Biologics Inc. (ADMA) has experienced a quarterly rise of 15.20% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 862.94M and boasts a workforce of 617 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 3.50, with a change in price of +0.06. Similarly, ADMA Biologics Inc. recorded 2,442,252 in trading volume during the last 100 days, posting a change of +1.55%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for ADMA stands at 0.99. Similarly, the long-term debt-to-equity ratio is also 0.99.
ADMA Stock Stochastic Average
Today, ADMA Biologics Inc.’s raw stochastic average for the past 50 days stands at 73.43%, indicating a rise from the raw stochastic average of the last 20 days, which was 65.38%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 72.42% and 77.71% respectively.
ADMA Stock Price Performance Analysis
The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. Year to date metric has recorded a gain of 1.55%.However, over the last six months, we can see a weaker performance of 21.98%. Over the last 30 days, the price of ADMA has fallen by 19.39%. And in the last five days, it has fallen by -2.48%.